Sartorius Stedim Biotech Patents – Insights & Stats

Sartorius Stedim Biotech has a total of 2308 patents globally, out of which 1281 have been granted. Of these 2308 patents, more than 61% patents are active. Germany is where Sartorius Stedim Biotech has filed the maximum number of patents, followed by USA and Europe. Parallelly, Germany seems to be the main focused R&D center and also is the origin country of Sartorius Stedim Biotech.

Sartorius Stedim Biotech subpart of Sartorius Ag. Sartorius Stedim Biotech develops and manufactures laboratory technologies and equipment for the pharma and food industries, as well as for public research institutes and laboratories. As of July 2022, Sartorius Stedim Biotech has a market cap of $30.77 Billion.

Do read about some of the most popular patents of Sartorius Stedim Biotech which have been covered by us in this article and also you can find Sartorius Stedim Biotech patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over Sartorius Stedim Biotech patent portfolio.

How many patents does Sartorius Stedim Biotech have?

Sartorius Stedim Biotech has a total of 2308 patents globally. These patents belong to 735 unique patent families. Out of 2308 patents, 1429 patents are active.

How Many Patents did Sartorius Stedim Biotech File Every Year?

Sartorius Stedim Biotech Patents Filing Trend

Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.

Year of Patents Filing or GrantSartorius Stedim Biotech Applications FiledSartorius Stedim Biotech Patents Granted
201110829
201211254
20138761
201413877
201512477
201617492
201716887
201818291
2019144112
2020139118
202149107
2022458

How many Sartorius Stedim Biotech patents are Alive/Dead?

Worldwide Patents

Sartorius Stedim Biotech Patents Portfolio

How Many Patents did Sartorius Stedim Biotech File in Different Countries?

Sartorius Stedim Biotech Worldwide Patents

Countries in which Sartorius Stedim Biotech Filed Patents

CountryPatents
Germany556
United States Of America500
Europe440
China145
Japan77
India40
Korea (South)33
Austria26
Denmark21
United Kingdom17
Canada15
Spain14
Singapore10
Australia10
France6
Israel5
Hong Kong (S.A.R.)5
Portugal3
Switzerland2
Brazil2
Norway2
Hungary1
Chile1
Russia1
South Africa1
Poland1
Mexico1
New Zealand1

Where are Research Centers of Sartorius Stedim Biotech Patents Located?

Research Centers of Sartorius Stedim Biotech Patents

10 Best Sartorius Stedim Biotech Patents

US7048775B2 is the most popular patent in the Sartorius Stedim Biotech portfolio. It has received 186 citations so far from companies like Ethicon Llc, Baxter International Inc and Cilag Gmbh International.

Below is the list of 10 most cited patents of Sartorius Stedim Biotech:

Publication NumberCitation Count
US7048775B2186
US6837995B1105
US6453683B195
DE202007005868U166
US6684646B265
US20080299652A163
US6623631B157
US6579445B253
USD632799S152
WO2009116002A146

Which Companies are using Sartorius Stedim Biotech Patents to Advance their Research?

If patents or patents from a particular technology area of a company receive a lot of citations, it implies that the technology is being followed and incrementally innovated by the citing companies. It also indicates that citing companies are working on similar and closely related technologies.

The top citing companies in the Sartorius Stedim Biotech patent portfolio are Life Technologies, Emd Millipore Corporation and Ge Healthcare Bio-Sciences Ab.

List of the top forward citing Companies –

CompanyNumber of Patents
Life Technologies12
Emd Millipore Corporation8
Ge Healthcare Bio-Sciences Ab5
Praxair5
Global Life Sciences Solutions Usa Llc5
Morgan Stanley Senior Funding Inc4
Eppendorf4
Apple3
Fremon Scientific Inc3
Boeing3

Count of 102 and 103 Type Rejections based on Sartorius Stedim Biotech Patents

Top Sartorius Stedim Biotech Patents used in Rejecting Most Patent Applications

Patent NumberCount of Rejected Applications
US8749396B223
US8982156B213
US8690129B211
US10119108B211
US6684646B210
US6579445B28
US8177123B28
US8426202B26
US8581738B26
US7513127B26
US9199202B26
US9044718B25
US9045722B25
US7425441B25
US6631616B25

What Percentage of Sartorius Stedim Biotech US Patent Applications were Granted?

Sartorius Stedim Biotech (Excluding its subsidiaries) has filed 386 patent applications at USPTO so far (Excluding Design and PCT applications). Out of these 292 have been granted leading to a grant rate of 89.5%.

Below are the key stats of Sartorius Stedim Biotech patent prosecution at the USPTO.

Which Law Firms Filed Most US Patents for Sartorius Stedim Biotech?

Law FirmTotal ApplicationsSuccess Rate
Hespos & Porco Llp18290.96%
Nixon & Vanderhye Pc2587.50%
Dilworth Ip Llc2375.00%
Chernoff Vilhauer Mcclung & Stenzel Llp2295.45%
Klarquist Sparkman Llp2080.00%
Edell Shapiro & Finnan Llc1560.00%
Proskauer Rose Llp14100.00%
Mcdonnell Boehnen Hulbert & Berghoff Llp1088.89%
Sughrue Mion Pllc771.43%
Crowell & Moring Llp6100.00%

EXCLUSIVE INSIGHTS COMING SOON!

What are Sartorius Stedim Biotech key innovation segments?

What Technologies are Covered by Sartorius Stedim Biotech?

The chart below distributes patents filed by Sartorius Stedim Biotech in different countries on the basis of the technology protected in patents. It also represents the markets where Sartorius Stedim Biotech thinks it’s important to protect particular technology inventions.

R&D Focus: How has Sartorius Stedim Biotech search focus changed over the years?

EXCLUSIVE INSIGHTS COMING SOON!

Interested in knowing about the areas of innovation that are being protected by Sartorius Stedim Biotech?

Related Articles

Alphapharm Patents – Insights & Stats (Updated 2024)

Alphapharm has a total of 108 patents globally, out of which 43 have been granted. Of these 108 patents, more than 18% patents are active. Australia is where Alphapharm has filed the maximum number of patents, followed by Europe (EPO) and United States of America. Parallelly, Australia seems to be

Read More »

Complexa Patents – Insights & Stats (Updated 2024)

Complexa has a total of 77 patents globally, out of which 16 have been granted. Of these 77 patents, more than 22% patents are active. The United States of America is where Complexa has filed the maximum number of patents, followed by Japan. Parallelly, United States of America seems to

Read More »

Leave a Comment

Fill the form to get the details:

Our comprehensive report provides an in-depth look into the patent portfolio. The report includes a breakdown of the patent portfolio across various technologies, listing the patent along with brief summaries of each patent's technology.